Results 11 to 20 of about 57,314 (316)

Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats

open access: yesJournal of Toxicology, 2017
Oral ketoconazole was recently the subject of regulatory safety warnings because of its association with increased risk of inducing hepatic injury. However, the relative hepatotoxicity of antifungal agents has not been clearly established.
Star Khoza, Ishmael Moyo, Denver Ncube
doaj   +2 more sources

Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance in Malassezia restricta

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Malassezia restricta is an opportunistic fungal pathogen on human skin; it is associated with various skin diseases, including seborrheic dermatitis and dandruff, which are usually treated using ketoconazole.
Minji Park   +3 more
semanticscholar   +1 more source

Evaluation of the efficacy and safety of ionic liquids containing ketoconazole in patients with tinea pedis: A randomized controlled clinical trial

open access: yesBioengineering & Translational Medicine, 2023
Ionic liquids (ILs) loading ketoconazole (KCZ) have shown better efficacy on rats with tinea pedis than the marketed Daktarin® but clinical studies are still lacking.
Xiying Wu   +10 more
doaj   +1 more source

Ketoconazole 2% cream versus a combination of ketoconazole 2% cream and adapalene 0.1% gel in the treatment of pityriasis versicolor

open access: yesAl-Azhar Assiut Medical Journal, 2022
Background and aim Pityriasis versicolor is a common chronic superficial fungal infection that manifests during or after puberty in hot humid temperatures.
Khaled M Tawfik   +2 more
doaj   +1 more source

Gynecomastia with Ketoconazole [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 1981
Three of forty men developed bilateral gynecomastia upon ketoconazole treatment. Symptoms abated despite continued therapy. This appears to be a direct drug effect on breast tissue.
John N. Galgiani   +2 more
openaire   +3 more sources

Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort

open access: yesFrontiers in Endocrinology, 2022
ObjectiveThe first-line treatment for Cushing’s disease is transsphenoidal surgery, after which the rates of remission are 60 to 80%, with long-term recurrence of 20 to 30%, even in those with real initial remission.
Camila Viecceli   +10 more
doaj   +1 more source

Study the Antifungal and Ocular Permeation of Ketoconazole from Ophthalmic Formulations Containing Trans-Ethosomes Nanoparticles

open access: yesPharmaceutics, 2021
Ketoconazole (KET), a synthetic imidazole broad-spectrum antifungal agent, is characterized by its poor aqueous solubility and high molecular weight, which might hamper its corneal permeation.
Tarek A. Ahmed   +3 more
doaj   +1 more source

Antifungal activity of silver nanoparticles in combination with ketoconazole against Malassezia furfur

open access: yesAMB Express, 2019
Malassezia furfur is lipophilic and lipid-dependent yeast, inhabitant of human skin microbiota associated with several dermal disorders. In recent years, along with the advances in nanotechnology and the incentive to find new antimicrobial drugs, there ...
J. Mussin   +5 more
semanticscholar   +1 more source

Treatment of Girls and Boys with McCune-Albright Syndrome with Precocious Puberty - Update 2017 [PDF]

open access: yes, 2017
The most common endocrinopathy associated with McCune-Albright Syndrome (MAS) is peripheral precocious puberty (PP) which occurs far more often in girls than in boys.
Eugster, Erica A., Neyman, Anna
core   +1 more source

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Home - About - Disclaimer - Privacy